These outcomes, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the strategy of focusing on ACKR3 as a unique solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-similar Diseases. By ticking this box https://pault581zwt2.ja-blog.com/profile